Dale Raine
Managing Director
Dr. Dale Raine is a Managing Director, Global Co-Head of BioPharma and Co-Head of European Healthcare at Lazard.
He has circa 20 years of experience advising healthcare clients on strategic advisory and capital markets transactions globally.
He joined Lazard in January 2016. Prior to this, he spent over 10 years at Deutsche Bank based in London and New York.
Previously, Dr. Raine was a postdoctoral research scientist in the Division of Molecular and Cellular Biology at Imperial College London and a visiting scientist in the Department of Chemistry at The Scripps Research Institute. He co-founded the International Malaria Proteome Consortium and contributed to the Malaria Genome Project. His research is published in a number of leading academic journals including Nature and Science.
Imperial College London - B.Sc. Biochemistry; M.Res. Infection and Immunology; Ph.D. Malaria Cell Biology.
Associate of the Royal College of Science.
Our offices in the United Kingdom
Lazard's first London office opened in 1877 on Old Broad Street, near the Bank of England and London's historic stock exchange, placing the firm's U.K. home at the meeting point of British capital, international trade, and the flows of finance.
The U.K. remains one of the largest operations in Lazard's global network, working closely with the firm's teams across continental Europe and the U.S., and in 2025 the firm moved its U.K. headquarters to 20 Manchester Square.
London continues to offer a single, integrated market where sovereign capital, listed companies, and global investors can flourish. From here, Lazard advises clients on a full range of strategic matters including mergers and acquisitions, restructuring and liability management, debt and capital structure, and capital raising. More than 175 years after the firm's founding, Lazard's client relationships in the U.K. still rest on a foundation of independent advice, discretion, and long-standing trust.